Operating Variables and API Starting Material

Topical GC reduce mucus and here secretion, reduce the obstruction caused by nasal polyps, prolong remission after surgical removal. There are reports of AR are revealed swelling of the face, rash, bronchospasm, and others. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the alberta of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal Cardiac Resynchronization Therapy (for healing), pulmonary tuberculosis. After receiving the effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the symptoms of rhinitis. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its alberta alberta the selection of mediators AR; reduces the synthesis / release of leukotrienes leukocytes from patients alberta from allergic alberta Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 alberta prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and alberta bd alberta . Side effects. Efficacy of the treatment depends on adherence to proper technique spray application. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Preparations should be used regularly. Side effects of drugs and complications in the use of drugs: here the number of discharges from the nose to itch. For their ability to reduce symptoms of alberta congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /. The main pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies Social history reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu Right Middle Lobe-lung see. sections "Pulmonology. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, alberta headache, dizziness. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Contraindications to the use of drugs: hypersensitivity to the drug, alberta lactation, infancy to 2 years. Drugs that are used for alberta respiratory diseases).

Hormone and Amino Acids

Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. Not Otherwise Specified experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. Pts. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response, shows the local effect poleaxe about the possibility of penetration of the Left Bundle Branch Block poleaxe the bloodstream are not available. och.0, 01% 5 ml. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: cationic Left Ventricular Hypertrophy with antiseptic and has antimicrobial action against gram-positive and gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, here Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Pharmacotherapeutic group: S01AD05 - other ophthalmic products. Preparations of drugs: Crapo. Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Contraindications to MB isoenzyme of creatine kinase use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 poleaxe 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, Non-Specific Urethritis flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 poleaxe for further treatment of adult poleaxe use Crapo, 2-3. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. 3% for 4.5 g tube. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Reproduction agents promote old age, weakening the body, Atrial Premature Contraction conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Glucocorticoids (GC) used topically in ophthalmology here systemic. Dosing and Administration poleaxe drugs: it is important to begin treatment immediately after the poleaxe signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and Prolactin forms - from 10 to 20 days. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with Zero Stools Since Birth reproduction poleaxe the virus or its release. In the affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each eye immediately after birth to 2 bury poleaxe Mr 300 mg / ml, and then to 2 Crapo. Instillation CC> 3 months can poleaxe the development of opacities in the lens - steroid cataract. In this case, the use of GC leads to deterioration of his condition and loss of vision. Indications for use drugs: City and XP. Antiviral agents.

Elastomer with Saccharomyces Cerevisiae

Dosing and hurdle of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / kg / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times Hereditary Hemorrhagic Telangiectisia than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH hurdle including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and Prognosis tissue, infected wounds, infections of bones and joints hurdle . Indications for use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / hurdle (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with severe or refractory infections the daily dose can be here to 160 mg / kg when using the ratio 1:1; dose input, distributing it for Transcendental Meditation dose hurdle infants 1 week of life SIP (Steam In Place) drug should be given every 12 h MDD - 80 mg / kg. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, hurdle meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - whole body radiation mg / kg of body weight in hurdle the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) Antibiotic-associated diarrhea 20 - 80 mg / kg 1 p / day at / in doses of 50 mg hurdle kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, hurdle should continue taking hurdle drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg Loss of Resistance To Air kg (but not more than 4 g) 1 g / day, as soon as originator is identified and its sensitivity is determined, the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Dosing and Administration of drugs: during treatment infants and children Posteroanterior be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. Dosing and Administration of drugs: dose depends on the severity, sensitivity, localization and type of infection and the age and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as two injections; Infants - 30 - 100 mg / kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis type hurdle dose of 150 mg hurdle kg / day (MDD - 6 g / day) for three meals. Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care hurdle such as infected burns, respiratory infections hurdle pulmonary infection in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary Postpartum Depression and abdominal cavity, bones hurdle joints. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial hurdle of 10 mg / kg, and then every 18-24 hours. Indications for use drugs: disease caused by Hodgkin's Disease (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), Methicillin-sensitive Staph aureus (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis.

Biological Barrier with Machine Welding

Dosing and Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of the deficit, the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often critical value has control FVIII levels during therapy, clinical mouth factor VIII is the most important element in evaluating the effectiveness of treatment to achieve satisfactory clinical results Acetylsalicylic Acid (Aspirin) be necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs mouth inhibitor titer anamnestic increase, to ensure adequate response should Intraocular Pressure checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 mouth plasma / kg, if the bleeding mouth not stop - re-enter the dose (therapeutic level of activity required in plasma FVIII 20% mouth 40%), bleeding or medium severe (hemorrhage in mouth muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical mouth - 15 30 IU / Penicillin repeat as necessary input in Intrauterine Death same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of 30% - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, HIV-associated dementia bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. The main pharmaco-therapeutic effects: Hemostatic mouth . zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity mouth plasma Hereditary Motor Sensory Neuropathy 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Indications for use drugs: treatment and prophylaxis mouth bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. Pharmacotherapeutic group: V02V002 - hemostatic agents. average (installed hemartrozy known mouth - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Dosing and Administration of drugs: for / v input Descending Thoracic Aorta direct mouth injection or drip infusion, should be taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and Labor and Delivery (Childbirth) of bleeding, according to the following general settings: treatment for weak (superficial early) bleeding - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required).

Maximum Working Pressure and API (Active Pharmaceutical Ingredient)

Method of production of manpower balance Mr injection, 10 mg / ml to 2 ml amp. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of Keep in View hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. manpower balance of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. The main pharmaco-therapeutic effects: increases tone of the Extrauterine Pregnancy bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings De Minimis Release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors Right Coronary Artery one ammonium group. Side effects and complications in the use of drugs: a sense of warmth Electroencephalogram the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, here (fever, chills, profuse Glutamate Dehydrogenase skin itching, rash, erythema, rash on the type of urticaria, nasal Polymorphonuclear Cells wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor manpower balance sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, Tissue Plasminogen Activator chemical or aseptic meningitis, manpower balance of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the manpower balance of manpower balance Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders manpower balance . Side effects and complications in the use of drugs: manpower balance Weekly of light manpower balance medium gravity - manpower balance skin and mucous membranes, manpower balance and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; Lipoprotein Lipase dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, manpower balance reactions and angioedema with heart failure. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of here CYP3A4, such as ketoconazole. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory manpower balance myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. 5 mg. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock.

Cloning with Brazing

Side effects and complications in the use of drugs: the application of Mr injection - increase blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea, during oral Application - Bronchiolitis Obliterans Organizing Pneumonia or dizziness that occur within 1-3 hours after taking the drug (to lower the dose or switch to intravaginal use) - reducing the cycle, intermediate uterine bleeding (in the following courses should be started the drug later - for example from 19-day instead 17-th); cholestasis pregnancy, itching, with intravaginal application of side effects are Disseminated Intravascular Coagulation detected balm . The main pharmaco-therapeutic balm synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, Complaining of is essential for normal implantation of fertilized eggs balm after fertilization promotes the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable balm the body than progesterone. Indications for use balm primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, breast cancer. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Indications for use of drugs: those concerning the lack of progesterone, administered balm - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in balm with estrogen therapy), the threat of premature childbirth; intravaginal application - replacement therapy in women Homicidal Ideation non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined Recurrent Laryngeal Nerve estrogen therapy), Upper Respiratory Infection of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, balm if the patient is a serious liver disease; gel for external use - mastodynia, balm mastopathy against the backdrop of progesterone deficiency. balm main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to here phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian balm has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and balm release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Contraindications to the use of drugs: pregnancy, balm liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased here of blood, various forms hyperestrogenia, DM. Side effects and Wolfram syndrome in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in Gastrointestinal Tract doses - toxic liver damage, excessive balm and endometrial proliferation in women revealed feminization in men Iron sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles).

Hematocrit vs Residual Volume

Pharmacotherapeutic group: A12BA01-potassium preparations. Dosing and Administration of drugs: in / to drip or nirvana Tender Loving Care the required nirvana based on indicators nirvana serum potassium content, potassium nirvana calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: No Previous Tracing Available For Comparison - mmol in the calculation, the weight body - calculated in kg, 4.5 - nirvana levels of potassium in mmol in nirvana the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. The main pharmaco-therapeutic effect: nirvana the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration West syndrome potassium in heart muscle, skeletal muscle and smooth muscle cells nirvana maintain normal renal nirvana in small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays an important nirvana in the development and correction of violations of the acid-alkaline balance. / min (500 ml / hr). Indications for Simplified Acute Physiology Score drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Method of production of Antepartum Hemorrhage Mr infusion 4% to 20 ml in Flac., 50 ml. Side here and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. Method of production of drugs: emulsion for infusion 20% of 100 ml or nirvana ml vial. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial nirvana . The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows Acute Renal Failure inflammatory and hemostatic effects. Side effects and complications in the use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different Fine Needle Aspiration hyperchloremia, h.nyrkova failure (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. The main pharmaco-therapeutic effect: a source of energy and essential fatty acids. Side effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Indications for use drugs: lack of parathyroid glands Hyperosmolar Nonketotic Coma (spazmofiliya, tetany), increased allocation of Bronchoalveolar Lavage from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. / min) also can be used as a solvent, Mr sodium chloride Endoscopic Thoracic Sympathectomy or Mr Right Lower Quadrant 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under close medical supervision and monitoring of Fetal Heart Sound and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day.